Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
StutterSense is a digital health company that develops AI-powered wearable technology designed to monitor and manage stuttering. The company's platform utilizes a discreet wearable sensor and machine learning algorithms to provide objective, real-time data on speech disfluency outside of clinical settings. By bridging the gap between speech-language pathology sessions and daily life, StutterSense aims to enhance the effectiveness of stuttering therapy and provide users with actionable insights into their speech patterns. The technology allows for continuous monitoring, which helps in identifying triggers and tracking progress more accurately than traditional self-reporting methods. Based in Ireland, the company focuses on empowering individuals with speech disorders through data-driven personalized care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on StutterSenseAI Therapeutics.